Variants in the SPINK5 gene result in defective expression of lymphoepithelial Kazal type inhibitor (LEKTI), resulting in activation of kallikrein (KLK5) and subsequent degradation and chronic inflammation of the epidermal barrier resulting in ichthyosiform desquamating erythroderma. The gene discussed is SPINK5; the disease is exfoliative dermatitis.